---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-26-034857"
form_type: "8-K"
ticker: "CRNX"
cik: "0001658247"
company_name: "Crinetics Pharmaceuticals, Inc."
filed_at: "2026-08-28T21:00:55+00:00"
generated_at: "2026-08-28T21:02:14.479630+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# Crinetics shareholders approve Vertex merger; closing expected Sept 1, 2026

## Summary
- Merger adoption approved: 79,240,098 for, 13,618 against, 10,915 abstain.
- Quorum of 74.71% (79,264,631 of 106,095,205 shares) represented at special meeting.
- Non-binding advisory compensation proposal rejected: 33,854,149 for, 44,803,403 against.
- Advisory vote failure not a condition; final closing condition now satisfied.
- Closing of Vertex acquisition expected on or about September 1, 2026.

## SEC filing metadata
- accession: 0001140361-26-034857
- form_type: 8-K
- ticker: CRNX
- cik: 0001658247
- company_name: Crinetics Pharmaceuticals, Inc.
- filed_at: 2026-08-28T21:00:55+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1658247/000114036126034857/0001140361-26-034857-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1658247/000114036126034857/ef20080970_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-26-034857
- JSON: https://secwatch.observer/filing/0001140361-26-034857.json
- Plain text: https://secwatch.observer/filing/0001140361-26-034857.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.